172 related articles for article (PubMed ID: 32243181)
1. Tumor Microenvironment Stimuli-Responsive Nanoparticles for Programmed Anticancer Drug Delivery.
Jia N; Li W; Liu D; Wu S; Song B; Ma J; Chen D; Hu H
Mol Pharm; 2020 May; 17(5):1516-1526. PubMed ID: 32243181
[TBL] [Abstract][Full Text] [Related]
2. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
3. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
[TBL] [Abstract][Full Text] [Related]
4. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells.
Liu D; Hu H; Zhang J; Zhao X; Tang X; Chen D
Chem Pharm Bull (Tokyo); 2011; 59(1):63-71. PubMed ID: 21212549
[TBL] [Abstract][Full Text] [Related]
5. Nano-drug delivery system with enhanced tumour penetration and layered anti-tumour efficacy.
Zhang N; Feng N; Xin X; Zhang J; Wu D; Jiang Q; Yu T; Gao M; Zhao S; Yang H; Tian Q
Nanomedicine; 2022 Sep; 45():102592. PubMed ID: 35905842
[TBL] [Abstract][Full Text] [Related]
6. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
8. Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis.
Zhang Z; Wang T; Yang R; Fu S; Guan L; Hou T; Mu W; Pang X; Liang S; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2020 Aug; 12(34):38499-38511. PubMed ID: 32805954
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
[TBL] [Abstract][Full Text] [Related]
10. In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation.
Li L; Zhang P; Li C; Guo Y; Sun K
Carbohydr Polym; 2021 Oct; 269():118268. PubMed ID: 34294300
[TBL] [Abstract][Full Text] [Related]
11. Stromal Barrier-Dismantled Nanodrill-Like and Cancer Cell-Targeted pH-Responsive Polymeric Micelles for Further Enhancing the Anticancer Efficacy of Doxorubicin.
Zhou C; Hu X; Liu Q; Wang L; Zhou Y; Jin Y; Ma Y; Liu Y
ACS Biomater Sci Eng; 2021 Dec; 7(12):5690-5705. PubMed ID: 34761919
[TBL] [Abstract][Full Text] [Related]
12. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive charge-conversional and NIR responsive bubble-generating liposomal system for synergetic thermo-chemotherapy.
Chen MM; Song FF; Feng M; Liu Y; Liu YY; Tian J; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2018 Jul; 167():104-114. PubMed ID: 29631221
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
[TBL] [Abstract][Full Text] [Related]
15. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.
Hu Q; Wang Y; Xu L; Chen D; Cheng L
Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053
[TBL] [Abstract][Full Text] [Related]
16. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
[TBL] [Abstract][Full Text] [Related]
17. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
[TBL] [Abstract][Full Text] [Related]
18. iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors.
Wang X; Zhao Y; Yan M; Liang X; Zhao N; Lu T
Eur J Pharm Sci; 2024 Apr; 195():106725. PubMed ID: 38346565
[TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
